Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Melanoma Research

Volumn 24, Issue 5, 2014, Pages 475-479

  Tas, Faruk ^a   Karabulut, Senem ^a   Bilgin, Elif ^a   Tastekin, Didem ^a   Duranyildiz, Derya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Fibronectin; Melanoma; Serum; Vitronectin

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DACARBAZINE; FIBRONECTIN; LACTATE DEHYDROGENASE; TEMOZOLOMIDE; VITRONECTIN; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; SKIN TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; VITRONECTIN; YOUNG ADULT;

EID: 84930061853     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000107     Document Type: Article

References (21)

1. Gaggioli C, Robert G, Bertolotto C, Bailet O, Abbe P, Spadafora A, et al. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. J Invest Dermatol 2007;127:400-410.
2. Kaariainen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, et al. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion. J Pathol 2006;210:181-191.
3. Haass NK, Smalley KS, Li L, Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005;18:150-159.
4. Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005;24:195-222.
5. Gaggioli C, Deckert M, Robert G, Abbe P, Batoz M, Ehrengruber MU, et al. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 2005;24:1423-1433.
6. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-540.
7. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986;233:467-470.
8. Gradilone A, Gazzaniga P, Cigna E, Vasaturo F, Vincenzi B, Gandini O, et al. Fibronectin and laminin expression in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 2007;157:398-401.
9. Janik ME, Przybyó M, Poché E, Pokrywka M, Litys̈ka A. Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin. Acta Biochim Pol 2010;57:55-61.
10. Hall DE. Vitronectin. In: Kreis T, Vale R, editors. Extracellular matrix, anchor, and adhesion proteins. New York: A Sambrook & Tooze Publication at Oxford University Press; 1999. pp. 496-498.
11. Felding-Habermann B, Fransvea E, O'Toole TEO, Manzuk L, Faha B, Hensler M. Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis 2002;19:427-436.
12. Bafetti LM, Young TN, Itoh Y, Stack MS. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 1998;273:143-149.
13. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res 1990;50:6757-6764.
14. Sanders LC, Felding-Habermann B, Mueller BM, Cheresh DA. Role of alpha V integrins and vitronectin in human melanoma cell growth. Cold Spring Harb Symp Quant Biol 1992;57:233-240.
15. Nip J, Brodt P. The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis. Cancer Metastasis Rev 1995;14:241-252.
16. Baroni A, Paoletti I, Silvestri I, Buommino E, Carriero MV. Early vitronectin receptor downregulation in a melanoma cell line during all trans retinoic acidinduced apoptosis. Br J Dermatol 2003;148:424-433.
17. Eliceiri BP, Cheresh DA. Role of integrins during angiogenesis. Cancer J 2000;6(Suppl 3):S245-S249.
18. Mitjans F, Meyer T, Fittschen C, Goodman S, Jonczyk A, Marshall JF, et al. In vivo therapy of malignant melanoma by means of antagonists of alphaV integrins. Int J Cancer 2000;87:716-723.
19. Seftor REB, Seftor EA, Hendrix MJ. Molecular role (s) for integrins in human melanoma invasion. Cancer Metastasis Rev 1999;18:359-375.
20. Sabatino M, Kim-Schulze S, Panelli MC, Stroncek D, Wang E, Taback B, et al. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin Oncol 2009;27:2645-2652.
21. Saito N, Nishimura H, Kameoka S. Clinical significance of fibronectin expression in colorectal cancer. Mol Med Rep 2008;1:77-81.